Article

Integrated analysis of LRP2 mutation to immunotherapy efficacy in pan-cancer cohort

2022-05-02

Abstract excerpt

<h4>Purpose: </h4> Immunotherapy has emerged as a novel therapy, while many patients are refractory. Although, several biomarkers have been identified as predictive biomarkers for immunotherapy, such as tumor specific genes, PD-1/PD-L1, tumor mutation burn (TMB), and microsatellite instability (MSI), results remain unsatisfactory. <h4>Methods: </h4> We investigated the characteristics of low-density lipoprotein re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 18ff4faf-4df5-5a5d-bfbc-f1650a7dab87
DOI: 10.21203/rs.3.rs-1503364/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrated analysis of LRP2 mutation to immunotherapy efficacy in pan-cancer cohortDOI 10.21203/rs.3.rs-1503364/v2Read

KMT2A/C mutations function as a potential predictive biomarker for immunotherapy in solid tumorsSemantic proximity Read

Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors.Semantic proximity Read

Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapySemantic proximity Read

Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts.Semantic proximity Read

Pan-Cancer Analysis Reveals RIPK2 Predicts Prognosis and Promotes Immune Therapy Resistance Via Triggering Cytotoxic T Lymphocytes DysfunctionSemantic proximity Read

Pan-cancer analysis reveals potential of RRM2 as a prognostic and immunological biomarker in human cancerSemantic proximity Read

A Comprehensive Tumor Molecular Profile Analysis in Clinical Practice: A Single Center’s ExperienceSemantic proximity Read

A Transcriptomic Meta-Analysis Identifies Differentially Expressed Genes across Different Types of Cancer and Their Association with Checkpoint Inhibitor ImmunotherapySemantic proximity Read

Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunctionSemantic proximity Read

Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironmentSemantic proximity Read

PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non-small cell lung cancer.Semantic proximity Read

Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy.Semantic proximity Read